Gelteq is trading at $0.53, up 7.75%, with no clear catalyst identified for the October 13, 2026 rise. - Available news results showed no Gelteq-specific announcement; the latest surfaced company updates were older. - Biotech-sector context was negative: XBI fell 2.01%, while major indexes were nearly flat, neither clearly explaining the gain. - Shares closed at $0.49 on October 12 after consecutive declines; available evidence does not establish why the rebound is occurring.